INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Narrative review / 2015

Evidence for resveratrol's protective effects in humans remains inconsistent compared to animal data, with many clinical studies limited by small sample sizes.

Pre-clinical findings indicate that resveratrol may protect against various medical conditions and age-related complications. However, there is no consistent evidence of increased protection against metabolic disorders and other ailments when comparing animal and human studies. The review notes that most human studies examining resveratrol administration and patient outcomes have been limited by sample sizes. It evaluates advances in timing, dosage, formulation, bioavailability, toxicity, and drug interactions, as well as disease actions in cancer, diabetes, neurodegeneration, and cardiovascular disease.

Study type
Narrative review
Who was studied
Human clinical studies of resveratrol
What was measured
Effects on cancer, diabetes, neurodegeneration, cardiovascular disease, and other ailments

THE PAPER

Resveratrol supplementation: Where are we now and where should we go?

Novelle MG, Wahl D, Diéguez C, Bernier M, de Cabo R. Ageing Res Rev, 2015.

PubMed 25625901 ↗DOI 10.1210/jc.2014-2799 ↗

Heart & arteriesDiabetes & blood sugarCancerBrain & moodHealthy aging & longevity

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.